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Kinins are key pro-inﬂammatory peptides that exhibit mitogenic effects in tissue-specific cellular systems. Since
the life span of the keratinocyte is regulated by receptors that control proliferation and differentiation, and since
both processes are affected during wound healing, we have examined the consequence of kinin B2 receptors (B2R)
activation in cultured human keratinocytes. Stimulation of keratinocytes by Lys-bradykinin (LBK) induced a rapid
and sustained phosphorylation of 42/44 mitogen-activated protein kinase (MAPK) that translocated to the nucleus,
and decreased only after 120 min of stimulation. Kinin B1 and B2 receptor (B1R and B2R) antagonists showed that
phosphorylation was mainly because of B2R activation. The GF109203X inhibitor almost completely abolished the
effect of LBK, suggesting the involvement of protein kinase C in the signal cascade. MAPK phosphorylation was
partially dependent on epidermal growth factor receptor transactivation as assessed by the selective inhibitor,
AG1478. LBK stimulation did not result in cell proliferation, but produced a rapid c-Fos expression, nuclear trans-
location of nuclear factor-jB, and a moderated (pro)ﬁlaggrin synthesis, indicating that it may modulate cell dif-
ferentiation. Our results support the view that kinins may affect the life span of human keratinocytes and highlight
the importance that kinin peptides may have in the pathogenesis and/or progression of skin diseases.
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Keratinocytes express several types of receptors, which
once activated may induce DNA synthesis or trigger cell
differentiation, events that may be relevant in the patho-
genesis and/or perpetuation of skin disorders. Kinins are
well-known vasoactive peptides, which exert their biological
action by activating specific surface expressed B1 and B2
receptors (Bhoola et al, 1992). Kinin receptors belong to the
superfamily of G protein-coupled receptors characterized
by seven-transmembrane spanning helices although they
differ in their primary structures, regulation of expression,
tissue distribution, and ligand profiles. The human kinin B1
receptor (B1R) is preferentially stimulated by Lys-des[Arg9]-
bradykinin, whereas both bradykinin (BK) and Lys-brad-
ykinin (LBK) activate the kinin B2 receptor (B2R). Most of
the cellular effects produced by kinins are mediated through
the B2R, that is constitutively expressed by many cell types
including the keratinocyte (Schremmer-Danninger et al,
1995). In contrast, the B1R seems to be functionally ab-
sent under normal conditions, but is rapidly upregulated
during the inflammatory response or after exposure to a
noxious stimuli (Marceau, 1995). The expression of both
mRNA and binding sites (Schremmer-Danninger et al, 1995,
1999), together with the immunoreactive substrates and the
enzyme responsible for kinin generation (Poblete et al,
1991; Hibino et al, 1994; Schremmer-Danninger et al, 1999),
have been reported in normal human skin. Functional stud-
ies have shown that BK induces phosphoinositide turnover
and 1,2-diglyceride formation (Talwar et al, 1990) and tyro-
sine phosphorylation of several proteins in cultured human
keratinocytes (Schremmer-Danninger et al, 1998).
Several studies have reported that kinins may increase
DNA synthesis and cell division in several cell systems
(Bhoola et al, 1992). some studies have, however, observed
that the B2R agonist BK either does not stimulate keratin-
ocyte proliferation (Johnson et al, 1992; Jung et al, 1999) or
induces a weak response when compared with that pro-
duced by epidermal growth factor (EGF) (Coutant and
Ryder, 1996). On the contrary, BK induces differentiation of
PC-12 cells to a magnitude, which is similar to that pro-
duced by nerve growth factor (Kozlowski et al, 1989). These
experiments were designed to analyze specific signaling
events triggered by the B2R agonist, LBK and to evaluate
the participation of this peptide in the proliferation and dif-
ferentiation of human keratinocytes. Our results demon-
strate that the in vitro stimulation of B2R induces 42/44
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mitogen-activated protein kinase (MAPK) phosphorylation,
which is partially dependent on EGF receptor (EGFR) trans-
activation. In addition, the MAPK phosphorylation pattern,
the rapid c-Fos expression, the nuclear factor-kB (NF-kB)
nuclear translocation, and the moderated (pro)filaggrin ex-
pression obtained after B2R stimulation provide telling
evidence for the modulation of keratinocyte differentiation
by B2R.
Results
Human keratinocytes in normal epidermis and in culture
express immunoreactive B2R The use of previously char-
acterized antibodies immunolabeled the B2R protein in ker-
atinocytes, that reside in the human epidermis (Fig 1a–c), as
well as following cell culture (Fig 1d, e). Immunoreactivity
was widely distributed throughout the whole epidermis, the
receptor protein being concentrated mainly on the cell
surface of keratinocytes (Fig 1b). A similar distribution was
observed for the cultured cells (Fig 1d). Omission and re-
placement of anti-B2R antibodies by non-immune rabbit
immunoglobulin (IgG) and absorption with an excess of the
same peptides used for immunization resulted in the ab-
sence of any staining in epidermal cells in situ (Fig 1c) or in
culture (Fig 1e).
Stimulation of keratinocytes with LBK induces 42/44
MAPK phosphorylation Under basal conditions (untreated
cells), MAPK was not significantly phosphorylated but when
the cells were stimulated with different doses of LBK, a
maximal response was achieved using 100 nM of the pep-
tide (Fig 2a). Stimulation of cells with LBK also produced a
sustained phosphorylation that lasted even after 120 min in
the presence of the agonist (Fig 2b). In contrast, the B1
agonist des[Arg9]-LBK induced a MAPK phosphorylation
that returned to basal levels 30 min after stimulation (Fig 3b).
Pre-treatment of keratinocytes with the kinin B2R antago-
nist (HOE140) prevented the phosphorylation induced by
LBK, whereas the B1R antagonists des[Arg9]-Leu8-BK and
des[Arg9]-Leu8-LBK (des[Arg10]-Leu8-kallidin) only had a
minimal effect (Fig 3a). On the contrary, both antagonists
prevented phosphorylation by des[Arg9]-LBK whereas
HOE140 had no effect (Fig 3c). These findings indicate that
LBK stimulate MAPK phosphorylation in human cultured
keratinocytes by activating the B2R.
Stimulation of keratinocytes with LBK produces the
translocation of phosphorylated 42/44 MAPK to the nu-
cleus In non-stimulated controls (0 min), immunoreactivity
to phosphorylated MAPK (P-MAPK) was weak, and equally
distributed in the cytoplasm and nucleus (Fig 4). After 5 min
of treatment with LBK, a strong reaction to P-MAPK, that
lasted over 30 min, was observed inside the nucleus (Fig 4).
No immunoreactivity was observed when an unrelated
mouse IgG, at the same concentration, replaced the pri-
mary antibody (not shown).
Effect of inhibitors and phorbol 12-myristate 13-acetate
(PMA) on 42/44 MAPK phosphorylation A significant re-
duction of MAPK phosphorylation was observed after pre-
incubation of keratinocytes with 1 mM of the protein kinase
C (PKC) inhibitor GF109203X, and a subsequent stimulation
with LBK (Fig 5). Experiments in which cells were directly
stimulated for short periods (15 min) with PMA demonstrat-
ed the availability of PKC to phosphorylate MAPK in human
keratinocytes. The lack of MAPK phosphorylation after
stimulation of cells with LBK prior to treatment with PMA for
a long period (24 h, to downregulate PKC) also suggested
the involvement of PKC (Fig 5). On the other hand, pre-
incubation of the cells with 50 mM of the mitogen-activated
protein kinase kinase (MEK) inhibitor PD98059 abolished
MAPK phosphorylation completely (Fig 5). Other inhibitors
Figure1
Human keratinocytes express immunoreactive kinin B2 receptors
(B2R). (a, b) Frozen sections of normal human skin immunostained with
the anti-B2R antisera mixture. Biotin–streptavidin–peroxidase ethyl-
carbazole system. (d) Visualization of kinin B2R in cultured human ker-
atinocytes by immunofluorescence. (c, e) Controls in which the anti-
B2R antibody was replaced by non-immune serum. Scale bar¼20 mm
(a); 7 mm (b); 10 mm (c–e).
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such as 1-butanol, brefeldin A, and wortmannin gave a
pattern of inhibition that was limited and only the latter
produced a discrete reduction of MAPK phosphorylation
(Fig 6). Keratinocytes pre-treated with 1 mM of the EGFR
kinase inhibitor, AG1478, completely abolished MAPK
phosphorylation when the cells were stimulated with 5 ng
per mL EGF for 5 min. Concentrations lower than 1 mM (i.e.
0.1–0.5 mM) had little effect (Fig 7a). When keratinocytes
were pre-treated with 1 mM AG1478, before stimulation with
LBK, MAPK phosphorylation was reduced but not to the
levels observed in untreated or EGF-stimulated cells pre-
treated with the same inhibitor (Fig 7b).
LBK does not induce keratinocyte proliferation To in-
vestigate the proliferative action of LBK, a range of peptide
concentrations (0.1–1000 nM) was tested. The 5-bromo-20-
deoxyuridine (BrdU) incorporation assay used revealed that
LBK failed to induce any significant cell proliferation (Fig 8).
This observation was confirmed when keratinocytes, grown
under identical conditions, responded in a concentration-
dependent manner to EGF stimulation (Fig 8). Keratinocyte
proliferation reached a plateau at 10 nM EGF. Other positive
controls, carried out when growing the cells in culture me-
dium containing growth factors, also exhibited a high BrdU
incorporation rate (not shown).
LBK activates NF-jB Immunofluorescence and western
blotting of nuclear and cytoplasmic extracts showed that
incubation of keratinocytes with 100 nM LBK produced a
rapid and significant translocation of NF-kB (p65) to the
nucleus (Fig 9). Immunofluorescence showed that LBK-in-
duced translocation was evident between 5 and 60 min of
treatment with the peptide (Fig 9a). Identification of p65 by
western blotting pointed out that immunoreactivity was
almost doubled in the nucleus of LBK-stimulated keratin-
ocytes (Fig 9b).
LBK induces a rapid expression of c-Fos Expression of
c-Fos was clearly visible after 1 h of stimulation and then
Figure 2
Lys-bradykinin (LBK) induces a sustained 42/44 mitogen-activated
protein kinase (MAPK) phosphorylation. Keratinocytes were incu-
bated with various concentrations of LBK for 5 min (a) or with 108 M
LBK for different periods of time (b). Cell proteins were separated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and trans-
ferred to nitrocellulose membranes that were immunoblotted with anti-
phosphorylated MAPK antibodies (P-MAPK, phosphorylated MAPK).
Antibodies were stripped and the membrane was incubated with anti-
total MAPK (T-MAPK) antibodies (phosphorylated and non-phosphory-
lated, T-MAPK). AU, arbitrary units. Blots are representative of four
independent experiments (n¼4).
Figure 3
The 42/44 mitogen-activated pro-
tein kinase (MAPK) phosphor-
ylation induced by Lys-bradykinin
(LBK) is mediated by B2 recep-
tors. (a) Keratinocytes were pre-in-
cubated with 106 M of the kinin B2
antagonist (HOE140), or the kinin
B1 antagonists des[Arg9]Leu8-BK
(ANT B1(a)) and des[Arg9]-Leu8-
LBK (ANT B1(b)) for 30 min and
then stimulated with 108 M LBK.
(b) Representative experiment us-
ing 108 M of the B1 agonist
des[Arg9]-LBK for the same periods
of time used in Fig 2. (c) Effect of
HOE140 and B1 antagonists on the
phosphorylation induced by des[Arg9]-LBK (LDBK). Values represent the
mean  SEM (n¼4). po0.01.
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declined gradually after 3–6 h (Fig 10a). Immunocytochem-
istry using the same antibody revealed intense c-Fos
immunoreactivity in the nuclei of keratinocytes after 1 h of
stimulation with the peptide (Fig 10b). c-Fos expression
under basal conditions and after 6 h of LBK stimulation was
almost undetectable.
B2R stimulation induces a moderated (pro)ﬁlaggrin syn-
thesis A clear expression of the terminal differentiation
marker, (pro)filaggrin, was observed in control experiments
carried out with the CD40 agonist M89 (Fig 11b). In contrast,
a moderated increase in (pro)filaggrin expression was ob-
served after stimulation with 100 nM LBK (Fig 11a). This
increase was reduced when stimulation of cells was carried
out in the presence of an excess of the HOE140, but only
partially when the B1R antagonist des[Arg9]-Leu8-BK was
used (Fig 11a). The effect produced by LBK was not ob-
served when keratinocytes were stimulated after reaching
confluence (not shown). By comparison, stimulation of ker-
atinocytes with an unrelated mouse IgG1 (control for M89)
at the same concentration did not induce (pro)filaggrin
expression in the same magnitude as that produced by the
M89 ligand.
Discussion
The existence of a kinin system in human skin is a well-
documented fact. The kinin-forming enzyme, tissue kallik-
rein, has been localized in the secretory fundus of sweat
glands (Poblete et al, 1991), and several authors have de-
scribed its biochemical properties (Mann et al, 1980; May-
field et al, 1989; Hibino et al, 1994). Recently, the mRNA for
true kallikrein (KLK1, tissue kallikrein, kininogenase) and
those for the B1R and B2R have been reported for the nor-
mal human skin, and in biopsies of patients with some skin
diseases (Schremmer-Danninger et al, 1999). Furthermore,
high-molecular-weight kininogen has been visualized in the
interstitial tissue space of guinea-pig epidermis (Yamamoto
et al, 1987), a fact also observed in the human epidermis
Figure 4
Lys-bradykinin (LBK) produces nuclear translocation of phos-
phorylated 42/44 mitogen-activated protein kinase (MAPK). Cells
were grown to subconfluence and then stimulated with 100 nM LBK for
5–30 min, fixed, permeabilized, and incubated with anti-P-MAPK
(phosphorylated MAPK) antibodies and with fluorescein-labeled F(ab0)2
anti-mouse immunoglobulin G. Scale bar¼25 mm.
Figure 5
42/44 mitogen-activated protein kinase (MAPK) phosphorylation is
mediated by protein kinase C (PKC) and mitogen-activated protein
kinase kinase (MEK). Cells were stimulated with 108 M Lys-brad-
ykinin (LBK) after pre-incubation with the PKC inhibitor GF109203X
(1 mM, for 30 min), the phorbolester phorbol 12-myristate 13-acetate
(PMA) (500 nM for 24 h), and the MEK inhibitor PD98059 (50 mM for
30 min). Additionally, keratinocytes were incubated directly with 50 nM
PMA for 15 min. Values represent the mean  SEM (n¼3). po0.05
and po0.01, with respect to LBK-stimulated cells.
Figure6
Effect of 1-butanol, brefeldin A, and wortmannin on 42/44 mitogen-
activated protein kinase (MAPK) phosphorylation. Keratinocytes
were stimulated with 108 M Lys-bradykinin (LBK) after 30 min of
pre-incubation with 2% v/v 1-butanol, 10 mg per mL brefeldin A (BFA),
and 50 nM wortmannin. Values represent the mean  SEM (n¼ 3).
po0.05, with respect to LBK-stimulated cells.
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when antibodies to both kininogens are used (C. D.
Figueroa, unpublished data). These data indicate that both
kallikreins and the kinin-containing substrates are normally
present in human skin, making viable the concept that
kinins are formed in this organ.
Our results indicate that the human epidermis and cul-
tured keratinocytes express immunoreactive and functional
B2R, which respond to agonist stimulation in vitro, with
42/44 MAPK phosphorylation, NF-kB nuclear translocation,
a rapid c-Fos expression, and a moderated (pro)filaggrin
synthesis. In contrast, B2R stimulation does not result in
keratinocyte proliferation, although high doses of the pep-
tide were used, an observation that is in agreement with
other studies in which this possibility had been investigated
(Johnson et al, 1992; Jung et al, 1999).
The MAPK phosphorylation induced by LBK was mainly
related to B2R stimulation, as demonstrated by the use of
two B1 and one B2 receptor antagonists. Moreover, the
phosphorylation pattern observed after stimulation of ker-
atinocytes with the B1 agonist des[Arg9]-LBK was com-
pletely different from that elicited by LBK. Time-course
experiments suggested that LBK might be associated to
keratinocyte differentiation, since sustained MAPK phos-
phorylation (up to 120 min) has been aligned to cell differ-
entiation rather than proliferation by other authors (Harada
et al, 2001). Moreover, one previous study shows that BK
causes the differentiation of PC-12 cells in a magnitude
similar to that produced by nerve growth factor and po-
tentiates the neurite-extending effect when added in com-
bination with the growth factor (Kozlowski et al, 1989).
Several studies have implicated transcription factors (which
Figure 7
Lys-bradykinin (LBK) induces a partial epidermal growth factor
receptor (EGFR) transactivation. (a) Keratinocytes were first pre-
treated with various concentrations of AG1478 for 30 min and then
stimulated with 5 ng per mL of EGF for 5 min. (b) In a separate set of
experiments, keratinocytes were pre-treated with 1 mM AG1478 for
30 min and then stimulated with 108 M LBK. Values represent the
mean  SEM (n¼ 3). po0.01.
Figure8
Lys-bradykinin (LBK) does not induce keratinocyte proliferation.
Cells were grown on 96-well plates and stimulated with various doses
of LBK (open circles) or epidermal growth factor (EGF) (closed circles).
The 5-bromo-20-deoxyuridine (BrdU) incorporation rate was deter-
mined by a colorimetric cell proliferation immunoassay and measuring
absorbance at 450 nm. Values represent the mean  SEM (n¼ 4).
po0.001; po0.0001.
Figure9
Lys-bradykinin (LBK) activates nuclear factor-j B (NF-jB) inducing
its translocation to the nucleus. (a) Cells were grown to subconflu-
ence and then stimulated with 100 nM LBK, fixed, permeabilized, and
incubated with an anti-p65 NF-kB subunit antibody and a fluorescein-
labeled F(ab0)2 anti-rabbit immunoglobulin G. Scale bar¼25 mm. (b)
Nuclear (N) and cytoplasmic (C) fractions, isolated from untreated and
LBK-stimulated cells, were run on sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis, transferred onto nitrocellulose, and immuno-
printed with anti-p65 antibody. Values represent the mean  SEM
(n¼3). po0.01.
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bind to AP-1 regulatory sites), and NF-kB as key regulators
of the keratinocyte differentiation program. Our experiments
indicate that stimulation of human keratinocytes with LBK
induces a rapid c-Fos expression. Previous studies on Ha-
Cat epidermal cells have shown that BK causes a rapid (10
min) and transient accumulation of c-Fos and c-Jun mRNA
(Coutant and Ryder, 1996). Further, a somewhat broader
pattern of distribution for c-Fos has been observed in the
spinous and granular layers, but almost completely absent
in the basal stratum of the normal human epidermis (Eckert
and Welter, 1996; Angel et al, 2001). This expression pattern
in proliferation-incompetent cells has led to the postulation
that in the human epidermis this AP-1-binding protein may
be linked to a differentiation program rather than cell pro-
liferation. Similarly, nuclear translocation of NF-kB has been
detected only in non-proliferative cells of the suprabasal
layers of human epidermis, suggesting a role for this mol-
ecule in the switch from proliferation to growth arrest and
differentiation. In fact, functional and pharmacological
blockade of NF-kB produces a hyperplastic epithelium
in vivo, whereas overexpression of active p50 and p65 NF-
kB subunits generates hypoplasia and growth inhibition
(Seitz et al, 1998). Our study shows that LBK activates NF-
kB inducing its nuclear translocation, thereby supporting a
role for B2R in the differentiation of human keratinocytes.
Interestingly, tumor necrosis factor-a and interferon-g,
which stimulate nuclear translocation of NF-kB, also inhib-
it keratinocyte proliferation (Takao et al, 2003), whereas lipo-
polysaccharide and dexamethasone do not activate NF-kB
and at the same time have a small effect on keratinocyte
proliferation. Our results add new evidence to early articles
on MAPK phosphorylation (Clerk et al, 1996; Velarde et al,
1999), NF-kB activation (Pan et al, 1996), and c-Fos ex-
pression (El-Dahr et al, 1998) in different cell systems after
B2R stimulation. An extra support for a role of B2R agonists
in keratinocyte differentiation is our observation of moder-
ated (pro)filaggrin expression following stimulation of sub-
confluent cells with LBK, a novel effect that has not been
described before in human keratinocytes. Comparative
control experiments carried out to activate CD40, a mole-
cule associated to keratinocyte differentiation (Concha et al,
2003), confirmed that the response evoked by LBK was
indeed moderated.
Finally, our results indicate that PKC is clearly implicated
in MAPK phosphorylation since the GF109203X inhibitor
completely abolished the stimulatory effect of LBK. Fur-
thermore, downregulation of PKC after prolonged phor-
bolester treatment resulted in a reduction of MAPK phos-
phorylation after stimulation with LBK. On the other hand,
the MAPK phosphorylation induced by LBK was not re-
duced by brefeldin A and 1-butanol, but it was partially di-
minished by wortmannin, a phosphoinositide 3 kinase
inhibitor. These experiments suggest that phospholipase D
and the small guanosine 50-triphosphate (GTP)-binding pro-
tein adenosine 50-diphosphate ribosylation factor (ARF) may
not participate in the differentiation program activated by
LBK. Previous studies have shown that BK activates
phospholipase D transiently, an effect that does not seem
to be of sufficient magnitude to trigger differentiation in
mouse keratinocytes.
Figure 10
Lys-bradykinin (LBK) induces an early expression of c-Fos. (a) Ker-
atinocytes were incubated for various periods of time with 108 M LBK.
Cell proteins were separated by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis and transferred onto nitrocellulose and
immunoprinted with anti-c-Fos antibody. Values represent the mean
 SEM (n¼ 3). (b) In parallel experiments, cells were fixed, permeabili-
zed, and immunostained with the anti-c-Fos antibody and the biotin/
streptavidin–peroxidase ethylcarbazole system. Scale bar¼ 25 mm.
Figure11
Lys-bradykinin (LBK) stimulates a moderated (pro)filaggrin syn-
thesis. (a) LBK (107 M) was used as a single dose and in the presence
of ANT B1(a) (the B1 receptor antagonist des[Arg9]Leu8-BK, 106 M) or
HOE140 (the B2R antagonist, 106 M). (b) As positive controls, kera-
tinocytes were stimulated with anti-CD40 monoclonal antibody, M89;
immunoglobulin (Ig) G1 is an isotype-matched mouse IgG used as a
control for M89. To ensure that an equal amount of protein is present in
each lane, the nitrocellulose membranes were stained with Coomassie
blue. Blots are representative of three independent experiments and
values represent the mean  SEM (n¼ 3). po0.05, with respect to
untreated cells and HOE140; po0.001, with respect to IgG1.
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Experiments orientated to elucidate whether LBK-stim-
ulated-MAPK phosphorylation was dependent on EGFR
transactivation showed that phosphorylation was only par-
tially mediated by EGFR activation, since the selective in-
hibitor of EGFR kinase, AG1478 (tyrphostin), did not reduce
MAPK phosphorylation to the levels observed in non-stim-
ulated or EGF-stimulated cells pre-treated with the inhibitor.
Transactivation of EGFR, mediated by stimulation of G pro-
tein-coupled receptors, occurs in diverse cell types (Daub
et al, 1997) and in several of these receptors, including the
B2R (Adomeit et al, 1999). Our results indicate that MAPK
phosphorylation induced by LBK is only partially regulated
by EGFR phosphorylation, confirming previous studies
showing that in addition to the ligand itself, EGFR transac-
tivation also depends on the cell type involved. A similar
observation has been reported for A431 cells where BK in-
dependently activates MAPK via a pathway that is sensitive
towards inhibitors of phosphoinositide 3 kinase and PKC,
but not to AG1478, corroborating that EGFR transactivation
is not necessarily a prerequisite for G protein-coupled re-
ceptors-induced activation of MAPK (Graness et al, 2000).
In summary, B2R agonists do not induce cell prolifera-
tion, but trigger a cellular pathway that may initiate a mild
keratinocyte differentiation, a response highly relevant for
the life span of keratinocytes during skin wound healing and
inflammation.
Materials and Methods
Tissue samples Patients who underwent reductive surgery and
had given written consent to the attending surgeon donated the
skin samples, which were used in this study. Written consent from
the patients and sample collection followed the guidelines stipu-
lated by the Medical Ethical Committee of Universidad Austral de
Chile and the Declaration of Helsinki principles.
Visualization of B2R Skin tissue samples were rapidly frozen in
liquid nitrogen and stored until use. Frozen sections (8 mm thick)
were air-dried and washed with PBS, pH 7.4. Next, they were
treated with 0.5% IgG-free bovine serum albumin (BSA) for 20 min
and then incubated with a mixture of well-characterized anti-pep-
tide antibodies (1:6000) directed to the intra- and extra-cellular
domains of the B2R (Figueroa et al, 1995), kindly provided by Prof.
Werner Mu¨ller-Esterl of the Institute for Biochemistry II, Johann
Wolfgang Goethe-University, Frankfurt, Germany. Bound IgG were
detected with the LSABþbiotin/streptavidin–peroxidase kit (Dako,
Carpinteria, California) and peroxidase was visualized by incuba-
tion with 3-amino-9-ethylcarbazol (Dako). Sections were finally
contrasted with hematoxylin and mounted with Mowiol (Polysci-
ences Inc., Warrington, Pennsylvania). Bound IgG were also de-
tected by a fluorescein-labeled F(ab0)2 anti-rabbit IgG. Controls
included omission of primary antibody, incubation of the anti-pep-
tide antibody with an excess of the same peptides used for im-
munization, or its replacement by non-immune serum of the same
origin (Figueroa et al, 1995).
Human keratinocyte culture Cultures were prepared as previ-
ously described (Concha et al, 2003). Briefly, skin pieces split cut
with a keratome device were incubated for 1 h at 371C with 0.05%
trypsin (Life Technologies, Rockville, Maryland) to obtain epidermal
sheets that were then pooled in Hanks’ balanced salt solution (Life
Technologies) supplemented with 10% fetal bovine serum (Hy-
clone, Logan, Utah). A single-cell suspension was prepared using a
fine scissors, repeated pipetting, and filtration through gauze. Ker-
atinocyte culture was established on lethally irradiated 3T3 fibro-
blast (10  103 cells per cm2) in a 3:1 mixture of Dulbecco’s-
modified Eagle’s and Ham’s F-12 media (Life Technologies) con-
taining 10% fetal bovine serum, 0.4 mg per mL hydrocortisone,
5 mg per mL insulin, 1010 M cholera toxin, 10 mg per mL EGF, and
antibiotics. Cells were cultured until subconfluence and then pass-
aged by dissociation with 0.25% trypsin-EDTA (Life Technologies)
and reseeded on irradiated fibroblasts. Cells were used after two or
three passages and in all experiments they were grown in a defined
keratinocyte serum-free and low calcium medium (DK-SFM; Life
Technologies).
MAPK phosphorylation Quiescent subconfluent keratinocytes
(grown for 24 h in the absence of growth factors) were stimulat-
ed with 0.1–1000 nM of LBK (Bachem Inc., Torrance, California) for
various periods of time. Experiments using 100 nM of the kinin B1
agonist des[Arg9]-LBK were carried out as a comparison. Stimu-
lation was stopped by addition of 100 mL of ice-cold RIPA buffer
(50 mM Tris-HCl, pH 7.4, containing 150 mM NaCl, 0.25% de-
oxycholic acid, 1% Nonidet P40, 1 mM EDTA, 1 mM Na3VO4, 250
mg per mL p-nitrophenyl phosphate, 1 mM phenylmethane–sulfonyl
fluoride, 1 mM NaF, 1 mg per mL leupeptin, 1 mg per mL pepstatin,
and 1 mg per mL aprotinin). Cells were scraped, sonicated, and the
amount of protein for each time point was measured. Equal
amount of protein (25 mg), dissolved in a sample buffer containing
2.5% mercaptoethanol, was subjected to 12.5% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then
electrotransferred onto nitrocellulose filters. After blocking of non-
specific-binding sites with 5% skimmed milk, blots were incubated
overnight with a monoclonal anti-phospho 42/44-MAPK antibody
(Cell Signaling Technology Inc., Beverly, Massachusetts) in 0.05 M
Tris-HCl containing 0.1% Tween 20 (Sigma, St. Louis, Missouri)
and 5% BSA. Bound antibodies were detected using a chemilu-
minescence kit (Pierce, Rockford, Illinois). The total amount of
MAPK present in each sample was assessed on the same mem-
brane using a polyclonal anti-MAPK antibody (1:1000). In some cell
types, this antibody reacts mainly with the 42-kDa band (Cell
Signaling Technology). For this purpose, the antibodies used for
the first immunodetection were previously stripped for 30 min at
501C with 62.5 mM Tris-HCl, pH7.4, containing 100 mM me-
rcaptoethanol and 2% SDS.
Effect of kinin receptor antagonists and inhibitors To establish
the kinin receptor type activated, quiescent keratinocytes were pre-
incubated for 30 min with an excess (106 M) of the HOE140
(Aventis Pharma Deutschland GmbH, Frankfurt, Germany) or the
B1R antagonists des[Arg9]-Leu8-BK (Sigma) and des[Arg9]-Leu8-
LBK (des[Arg10]-Leu8-kallidin; Bachem Inc.). To investigate the
pathway involved in MAPK phosphorylation, cells were pre-incu-
bated for 30 min with 1 mM GF109203X (Calbiochem), a PKC in-
hibitor; 50 mM PD98059 (Calbiochem, San Diego, California), an
MAPKK (MEK) inhibitor; 50 nM PMA for 15 min or 500 nM for 24 h;
10 mg per mL brefeldin A, an inhibitor of small GTP-binding protein
ARF; 2% v/v 1-butanol, a phospholipase D inhibitor, and 50 nM
wortmannin, a phosphoinositide 3 kinase inhibitor. The potent and
selective inhibitor of EGFR kinase, AG1478 (tyrphostin), was used to
determine whether MAPK phosphorylation was influenced by EGFR
transactivation. For this purpose, cells were pre-incubated with 1
mM of AG1478 for 30 min and then stimulated with LBK (108 M) for
5 min. The concentration of AG1478 to be used was determined
by pre-incubating keratinocytes with various concentrations of the
inhibitor before stimulation with EGF (5 ng per mL) for 5 min.
Cell proliferation assay Keratinocytes were seeded on 96-well
plates and cultured at subconfluence. After 48 h in the absence of
growth factors, cells were stimulated with various doses of LBK.
The culture medium was changed after 24 h, the cells stimulated
again with the same dose of LBK, and pulsed with BrdU for another
24 h. The incorporation rate of BrdU was determined by a colori-
metric immunoassay according to the manufacturer’s protocol
(Roche Diagnostics GmbH, Penzberg, Germany). Control experi-
ments were carried out stimulating keratinocytes with EGF. Four
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experiments were carried out for each concentration point and
each point was performed in duplicate.
Activation of the transcription factors c-Fos and NF-jB Acti-
vation of c-Fos and NF-kB was investigated by western blotting
and immunocytochemistry using commercial antibodies (Santa
Cruz Biotechnology Inc., Santa Cruz, California). The antibody to c-
Fos, directed to the amino terminus of the human molecule, does
not cross-react with Fos B, Fra-1, or Fra-2. NF-kB was identified
using an antibody that recognizes the 65 kDa subunit. For western
blotting, both antibodies were used at a 1:1000 dilution. In addi-
tion, activation of NF-kB was assessed on cytoplasmic and nuclear
extracts using the method of Gerber et al (1992). Briefly, quiescent
keratinocytes were stimulated with 100 nM LBK for 60 min as de-
scribed before and then lysed with 400 mL of extraction buffer
(10 mM HEPES, pH 7.9, 1 mM EDTA, 1 mM EGTA, 10 mM KCl, 1
mM dithiothreitol, 1 mg per mL leupeptin, 1 mg per mL aprotinin,
and 1 mM phenylmethane–sulfonyl fluoride). After 20 min on ice,
25 mL of 10% Nonidet P-40 was added and then centrifuged
10,000 g. for 2 min at 41C. The supernatant (cytoplasmic extract)
was collected and the pellet treated with nuclear extraction buffer
(20 mM HEPES, pH 8.0, 1 mM EDTA, 1 mM EGTA, 0.4 M NaCl,
1 mM dithiothreitol, 1 mg per mL leupeptin, 1 mg per mL aprotinin,
and 1 mM phenylmethane–sulfonyl fluoride), vortexed for 1 min
and left to stand on ice for 10 min. After centrifugation 10,000 g. for
10 min at 41C, the supernatant (nuclear extract) was collected.
Proteins of both extracts were separated by SDS-PAGE and p65
subunit detected by chemiluminescence as described above.
Immunocytochemistry The intracellular distribution of P-MAPK,
NF-kB, and c-Fos was investigated by stimulating keratinocytes,
grown on permanox tissue culture chambers (Nunc Brand Prod-
ucts, Naperville, Illinois), with 100 nM LBK. Cells fixed for 10 min
with 4% paraformaldehyde dissolved in PBS, pH 7.4, were perm-
eabilized with methanol at 201C and incubated with anti-phospho
42/44-MAPK (1:100), anti-p65 (1:20), or anti-c-Fos (1:800). Bound
IgG were detected with the aid of fluorescein-labeled F(ab0)2 an-
tibodies (Roche Diagnostics GmbH) or with the LSABþ kit to in-
crease sensitivity (Dako).
Evaluation of (pro)ﬁlaggrin expression Expression of (pro)filag-
grin has been widely used to evaluate keratinocyte terminal differ-
entiation and under SDS-PAGE is normally observed as a 400 kDa
product accompanied by several proteolytic breakdown products
(Fleckman et al, 1985). Quiescent subconfluent keratinocytes were
stimulated once with 100 nM LBK and cultured for 2 extra days.
The (pro)filaggrin production was estimated by SDS-PAGE on a
6% polyacrylamide gel and immunoprinting with the AKH-1 mono-
clonal antibody (1:1000; Biomedical Technologies, Stoughton,
Massachusetts). Controls were carried out simultaneously by
culturing cells in the absence of ligand and using B1R and B2R
antagonists. Positive controls were performed with the M89 mono-
clonal antibody that activates CD40 to elicit keratinocyte differen-
tiation; its specificity was assessed by replacing M89 by an
unrelated mouse IgG1 (Concha et al, 2003). Homogenates were
prepared in 50 mM Tris-HCl, pH 7.4, containing 150 mM NaCl,
1 mM EDTA, 1 mM EGTA, 1 mM b-mercaptoethanol, 9 M urea,
1 mM phenylmethane–sulfonyl fluoride, 1 mM NaF, 1mM Na3VO4,
1 mg per mL aprotinin, 1 mg per mL pepstatin, and 1 mg per mL
leupeptin).
Quantitative image analysis The intensity of immunoreactive
protein bands, visualized after immunoblotting, was quantified us-
ing an automated image digitizing system (Un-Scan-It, Silk Scien-
tific Inc., Orem, Utah) as previously described (Figueroa et al,
2001).
Statistical analysis Statistical evaluation of intensity in immuno-
blots and cell proliferation assays was carried out with the Student
t test. Values are expressed as mean  SEM, and significance was
considered acceptable at the 5% level (po0.05).
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